Table 2 Comparison of the asymptomatic candidiasis and symptomatic candidiasis groups, in terms of demographic characteristics and P values.

Age (months)

0-3

0

0.0

2

6.5

0.014

4-12

17

47.2

12

38.7

13-60

15

41.7

6

19.4

60+

4

11.1

11

35.5

Gender

Female

13

36.1

13

41.9

0.626

Male

23

63.9

18

58.1

Candida spp.

Albicans

20

55.6

8

25.8

0.204

Tropicalis

2

5.6

3

9.7

Parapsilosis

8

22.2

15

48.4

Glabrata

3

8.3

1

3.2

Kefyr

1

2.8

1

3.2

Sake

1

2.8

1

3.2

Kefyr + Albicans

0

0.0

1

3.2

Albicans + Tropicalis

1

2.8

1

3.2

Central venous catheter

No

17

47.2

1

3.2

< 0.0001

Femoral

18

50.0

27

87.1

Jugular

1

2.8

1

3.2

Femoral + Jugular

0

0.0

2

6.5

Broad-spectrum antibiotic use

No

2

5.6

0

0.0

0.111

Yes

34

0.0

31

100.0

Blood transfusion

No

7

19.4

1

3.2

0.060

Yes

29

80.6

30

96.8

Corticosteroid use

No

19

52.8

20

64.5

0.331

Yes

17

47.2

11

35.5

Parenteral nutrition

No

21

58.3

0

0.0

< 0.0001

Yes

15

41.7

31

100.0

Surgery

No

30

83.3

17

54.8

0.011

Yes

6

16.7

14

45.2

Prognosis

Survived

22

61.1

16

51.6

0.434

Died

14

38.9

15

48.4